NATIONAL HEALTH CARE
Adcock Ingram CEO Andy Hall upbeat about NHI Bill
29 August 2019 - 05:10
The CEO of SA’s second-largest generic drug manufacturer sought to allay fears that the government’s drive for universal health coverage poses a risk to the pharmaceutical sector, saying the reforms proposed under the National Health Insurance (NHI) Bill could boost drug sales.
Adcock Ingram CEO Andy Hall’s view is in contrast to the negative investor sentiment that greeted the August 8 release of the bill. The first piece of proposed legislation for the government’s planned health sector reforms saw R14bn wiped off the value of key health-care stocks in the space of three days...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.